Overview
RemImazolam Besylate for ICU-sedation in Patients With Mechanical Ventilation After Oral and Maxillofacial Surgery
Status:
Recruiting
Recruiting
Trial end date:
2024-12-31
2024-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
Remimazolam besylate, as a new benzodiazepine drug, has few advantages in respiratory depression and gastrointestinal motility. The study will further explore the safety and effectiveness of remimazolam besylate n the sedation of mechanically ventilated patients after oral and maxillofacial surgery in the ICUPhase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Nanfang Hospital of Southern Medical UniversityTreatments:
Midazolam
Propofol
Criteria
Inclusion Criteria:- Age ≥18 years old
- mechanical ventilation patients with expected ICU stay time <72h
- People who need immediate sedative treatment
Exclusion Criteria:
- pregnancy;
- can not get RASS score from patients
- allergy to drugs